PCMC
PACB icon

Planning Capital Management Corporation’s Pacific Biosciences PACB Stock Holding History

Planning Capital Management Corporation’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$34 Hold
20
– – ﹤0.01% 754
2024
Q2 		$28 Buy
+20
New +$40 ﹤0.01% 698

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Planning Capital Management Corporation's PACB Position: Q3 2024 in Review

Planning Capital Management Corporation held its Pacific Biosciences (PACB) position steady in Q3 2024 at 20 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #754.

Planning Capital Management Corporation first reported a position in PACB in Q2 2024 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • Planning Capital Management Corporation held 20 shares of Pacific Biosciences worth $34 as of Q3 2024.
  • Planning Capital Management Corporation left its Pacific Biosciences share count unchanged in Q3 2024.
  • Pacific Biosciences made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #754 holding.
  • Planning Capital Management Corporation first reported a position in Pacific Biosciences in Q2 2024 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.